Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Fallopian Tube Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Triple Negative Breast Neoplasms

NCT04043195 2025-05-28

NSCLC

Phase 1/2 Active not recruiting

30 enrolled

Thoracic

Advanced NSCLC

NCT06926790 2025-04-22

GALAXY 3

Phase 2 Recruiting

69 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05144529 2025-04-17

TOP2101

Phase 2 Active not recruiting

38 enrolled

Thoracic

Lung Cancer Metastatic

NCT04141644 2025-04-16

Osi+Ipi

Phase 1 Active not recruiting

24 enrolled

Thoracic

Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor (Disorder)

NCT05012254 2025-04-09

NIVIPI-Brain

Phase 2 Active not recruiting

71 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms

NCT03262779 2025-01-09

Ipilimumab and Nivolumab in Patients With Anti-PD-1-axis Therapy-resistant Advanced Non-small Cell Lung Cancer.

Phase 2 Completed

20 enrolled 16 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03043599 2024-12-20

Ipilimumab + Nivolumab w/Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer

Phase 1/2 Completed

21 enrolled 11 charts

Thoracic

Small Cell Lung Carcinoma

NCT05501665 2024-10-17

Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer

Phase 1/2 Recruiting

25 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06492421 2024-07-09

Neoadjuvant Intra-tumor Double Immunotherapy for Lung Cancer.

Phase 2 Recruiting

90 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04610658 2024-04-02

Immune Checkpoint Inhibition With Lurbinectedin Relapsed/Recurrent SCLC

Phase 1 Terminated

9 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT04300244 2024-02-29

NIPU

Phase 2 Active not recruiting

118 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant, Lung Neoplasms, Mesothelioma, Neoplasms

NCT03083691 2024-01-17

BIOLUMA: Biomarkers for Nivolumab and Ipilimumab and Evaluation of the Combination in Lung Cancer

Phase 2 Completed

90 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT05041062 2024-01-03

A Study of Immunotherapy Drugs Nivolumab and Ipilimumab in Patients w/Resectable Malignant Peritoneal Mesothelioma

Phase 2 Completed

2 enrolled 8 charts

Other solid neoplasmThoracic

Lung Neoplasms, Mesothelioma

NCT04591431 2023-10-03

ROME

Phase 2 Unknown

400 enrolled

BreastGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms

NCT03509584 2023-06-15

Phase I Multicenter Trial Combining Nivolumab, Ipilimumab and Hypo-fractionated Radiotherapy for Pretreated Advanced Stage Non-small Cell Lung Cancer Patients

Phase 1 Terminated

6 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03168464 2023-04-24

Radiation and Immune Checkpoints Blockade in Metastatic NSCLC (BMS # CA209-632)

Phase 1/2 Terminated

15 enrolled 9 charts

Thoracic

Non Small Cell Lung Cancer Metastatic

NCT03406715 2023-03-30

Combination Immunotherapy-Ipilimumab-Nivolumab-Dendritic Cell p53 Vac - Patients With Small Cell Lung Cancer (SCLC)

Phase 2 Terminated

14 enrolled 12 charts

Thoracic

Lung Diseases, Lung Neoplasms, Small Cell Lung Carcinoma

NCT03351361 2023-03-01

eNERGY

Phase 3 Completed

217 enrolled

Thoracic

Advanced Non Small Cell Lung Cancer

NCT04107168 2023-02-16

Microbiome Immunotherapy Toxicity and Response Evaluation

Unknown

1,800 enrolled

DermatologicGenitourinaryThoracic

Kidney Neoplasms, Lung Neoplasms, Melanoma

NCT03663166 2023-02-15

Radiation and Chemotherapy With Ipilimumab Followed by Nivolumab for Patients With Stage III Unresectable Non-Small Cell Lung Cancer (NSCLC)

Phase 1/2 Terminated

19 enrolled 12 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05597800 2022-10-28

LUNGVIR

Phase 2 Not yet recruiting

105 enrolled

Thoracic

Post-Acute COVID-19 Syndrome, Carcinoma, Non-Small-Cell Lung

NCT04571632 2022-09-14

Luscid

Phase 2 Unknown

36 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04434560 2022-07-26

Neoadjuvant Immunotherapy in Brain Metastases

Phase 2 Terminated

1 enrolled 7 charts

BreastCNSDermatologicGenitourinaryGynecologicThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Melanoma, Ovarian Neoplasms, Triple Negative Breast Neoplasms

NCT03091491 2022-06-14

Study of Nivolumab Verses Nivolumab and Ipilimumab Combination in EGFR Mutant Non-small Cell Lung Cancer

Phase 2 Terminated

31 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung